Endoscopic ultrasound (US)-guided radiofrequency ablation (RFA) has been investigated for pancreatic ductal adenocarcinoma (PDAC) but studies are limited and heterogeneous. Computed tomography (CT) scan features may predict RFA response after chemotherapy but their role is unexplored. The primary aim was to investigate the efficacy of ex-vivo application of a dedicated RFA system at three power on surgically resected PDAC in patients who underwent neoadjuvant chemotherapy. The secondary aim was to explore the association between pre-treatment CT-based quantitative features and RFA response.

Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy / Rossi, Gemma; Petrone, Maria Chiara; Schiavo Lena, Marco; Albarello, Luca; Palumbo, Diego; Testoni, Sabrina Gloria Giulia; Archibugi, Livia; Tacelli, Matteo; Zaccari, Piera; Vanella, Giuseppe; Apadula, Laura; Crippa, Stefano; Belfiori, Giulio; Reni, Michele; Falconi, Massimo; Doglioni, Claudio; De Cobelli, Francesco; Healey, Andrew J; Capurso, Gabriele; Arcidiacono, Paolo Giorgio. - In: DEN OPEN. - ISSN 2692-4609. - 3:1(2023). [10.1002/deo2.152]

Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy

Palumbo, Diego;Testoni, Sabrina Gloria Giulia;Archibugi, Livia;Tacelli, Matteo;Vanella, Giuseppe;Crippa, Stefano;Belfiori, Giulio;Reni, Michele;Falconi, Massimo;Doglioni, Claudio;De Cobelli, Francesco;Capurso, Gabriele
Penultimo
;
Arcidiacono, Paolo Giorgio
Ultimo
2023-01-01

Abstract

Endoscopic ultrasound (US)-guided radiofrequency ablation (RFA) has been investigated for pancreatic ductal adenocarcinoma (PDAC) but studies are limited and heterogeneous. Computed tomography (CT) scan features may predict RFA response after chemotherapy but their role is unexplored. The primary aim was to investigate the efficacy of ex-vivo application of a dedicated RFA system at three power on surgically resected PDAC in patients who underwent neoadjuvant chemotherapy. The secondary aim was to explore the association between pre-treatment CT-based quantitative features and RFA response.
2023
endoscopic ultrasound
ex‐vivo
neoadjuvant chemotherapy
pancreatic adenocarcinoma
radiofrequency ablation
File in questo prodotto:
File Dimensione Formato  
DEN Open - 2022.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Creative commons
Dimensione 1.1 MB
Formato Adobe PDF
1.1 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/134904
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact